Clinical Trials
Source: CCM
- Score: 4Digestive System
The OPTIMIZE Trial
- Ages18 years - 80 years
- GenderBoth
- Score: 1Phase 1 Cancers
An Open-Label Study of GV20-0251 in Patients With Advanced and/or Refractory Solid Tumor Malignancies
- Score: 0Gynecological Cancers
A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer
- GenderFemale only